USE OF VALUE OF INFORMATION IN UK HEALTH TECHNOLOGY ASSESSMENTS

International Journal of Technology Assessment in Health Care

Volumn 30, Issue 6, 2014, Pages 553-570

  Mohiuddin, Syed ^a   Fenwick, Elisabeth ^b   Payne, Katherine ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Decision making; Health technology assessment; Research prioritization; Systematic review; Value of information

Indexed keywords

DECISION MAKING; HEALTH;

ECONOMIC MODELING; ENGLAND AND WALES; HEALTH TECHNOLOGY ASSESSMENTS; PERFECT INFORMATIONS; PRIORITIZATION; SAMPLING INFORMATION; SYSTEMATIC REVIEW; VALUE OF INFORMATION;

INFORMATION USE;

ARTICLE; DECISION MAKING; HEALTH CARE QUALITY; HEALTH TECHNOLOGY ASSESSMENT; HUMAN; METHODOLOGY; SYSTEMATIC REVIEW (TOPIC); UNITED KINGDOM; VALUE OF INFORMATION; BIOMEDICAL TECHNOLOGY ASSESSMENT; COST BENEFIT ANALYSIS; PROCEDURES; QUALITY ADJUSTED LIFE YEAR; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

COST-BENEFIT ANALYSIS; DATA INTERPRETATION, STATISTICAL; DECISION MAKING; GREAT BRITAIN; HUMANS; MODELS, ECONOMETRIC; QUALITY-ADJUSTED LIFE YEARS; RESEARCH DESIGN; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84926475674     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462314000701     Document Type: Article

References (38)

1. Akehurst RL. Making decisions on technology availability in the British National Health Service-why we need reliable models. Value Health. 2003;6:3-5.
2. Brennan A, Chick SE, Davies R. A taxonomy of model structures for economic evaluation of health technologies. Health Econ. 2006;15:1295-1310.
3. Claxton K. Exploring uncertainty in cost-effectiveness analysis. Pharmacoeconomics. 2008;26:781-798.
4. NICE. Guide to the methods of technology appraisal. 2004. http://www.nice.org.uk/niceMedia/pdf/TAP-Methods.pdf (accessed November 28, 2013).
5. ClaxtonK.Bayesian approaches to the value of information: Implications for the regulation of newpharmaceuticals. Health Econ. 1999;8:269-274.
6. Claxton K, Ginnelly L, Sculpher M, Philips Z, Palmer S. A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme. Health Technol Assess. 2004;8:1-103, iii.
7. Felli JC, Hazen GB. Sensitivity analysis and the expected value of perfect information. Med Decis Making. 1998;18:95-109.
8. Strong M, Oakley JE. An efficient method for computing singleparameter partial expected value of perfect information. Med DecisMaking. 2013;33:755-766.
9. Groot Koerkamp B, Myriam Hunink MG, Stijnen T, Weinstein MC. Identifying key parameters in cost-effectiveness analysis using value of information: A comparison of methods. Health Econ. 2006;15:383-392.
10. Ades AE, Lu G, Claxton K. Expected value of sample information calculations in medical decision modeling. Med Decis Making. 2004;24:207-227.
11. Coyle D, Buxton MJ, O'Brien BJ.Measures of importance for economic analysis based on decision modeling. J Clin Epidemiol. 2003;56:989-997.
12. Claxton K, Thompson KM. A dynamic programming approach to the efficient design of clinical trials. J Health Econ. 2001;20:797-822.
13. Myers E, Sanders GD, Ravi D, et al. Evaluating the potential use of modeling and value-of-information analysis for future research prioritization within the evidence-based practice center program. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011. http://www.ncbi.nlm.nih.gov/books/NBK62134/ (accessed December 20, 2013).
14. Carlton J, Karnon J, Czoski-Murray C, Smith KJ, Marr J. The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: A systematic review and economic evaluation. Health Technol Assess. 2008;12:iii, xi-194.
15. Grant A, Wileman S, Ramsay C, et al. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastrooesophageal reflux disease - a UK collaborative study. The REFLUX trial. Health Technol Assess. 2008;12:1-181, iii-iv.
16. McKenna C, Burch J, Suekarran S, et al. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure. Health Technol Assess. 2010;14:1-162.
17. Speight PM, Palmer S, Moles DR, et al. The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess. 2006;10:1-144, iii-iv.
18. Bhattacharya S, Middleton LJ, Tsourapas A, et al. Hysterectomy, endometrial ablation and Mirena® for heavy menstrual bleeding: A systematic review of clinical effectiveness and cost-effectiveness analysis. Health Technol Assess. 2011;15:iii-xvi, 1-252.
19. Black C, Clar C, Henderson R, et al. The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: A systematic review and economic evaluation. Health Technol Assess. 2009;13:1-148.
20. Collins R, Fenwick E, Trowman R, et al. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer. Health Technol Assess. 2007;11:iii-iv, xv-xviii, 1-179.
21. Fox M, Mealing S, Anderson R, et al. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: Systematic review and economic model. Health Technol Assess. 2007;11:iii-iv, ix-248.
22. Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N. Surveillance of Barrett's oesophagus: Exploring the uncertainty through systematic review, expert workshop and economic modelling. Health Technol Assess. 2006;10:1-142, iii-iv.
23. McKenna C, McDaid C, Suekarran S, et al. Enhanced external counterpulsation for the treatment of stable angina and heart failure: A systematic review and economic analysis. Health Technol Assess. 2009;13:iii-iv, ix-xi, 1-90.
24. Thompson Coon J, Rogers G, Hewson P, et al. Surveillance of cirrhosis for hepatocellular carcinoma: Systematic review and economic analysis. Health Technol Assess. 2007;11:1-206.
25. Hewitt C, Gilbody S, Brealey S, et al. Methods to identify postnatal depression in primary care: An integrated evidence synthesis and value of information analysis. Health Technol Assess. 2009;13:1-145, 147-230.
26. Colbourn T, Asseburg C, Bojke L, et al. Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: Cost-effectiveness and expected value of information analyses. Health Technol Assess. 2007;11:1-226, iii.
27. Clegg AJ, Loveman E, Gospodarevskaya E, et al. The safety and effectiveness of different methods of earwax removal: A systematic review and economic evaluation. Health Technol Assess. 2010;14:1-192.
28. Brush J, Boyd K, Chappell F, et al. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: A systematic review and economic evaluation. Health Technol Assess. 2011;15:1-192, iii-iv.
29. Chen Y-F, Madan J, Welton N, et al. Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation:Asystematic review and network meta-analysis. Health Technol Assess. 2012;16:1-205, iii-v.
30. Castelnuovo E, Thompson-Coon J, Pitt M, et al. The cost-effectiveness of testing for hepatitis C in former injecting drug users. Health Technol Assess. 2006;10:iii-iv, ix-xii, 1-93.
31. Robinson M, Palmer S, Sculpher M, et al. Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: Systematic reviewand decision-analytical modelling. Health Technol Assess. 2005;9:iii-iv, ix-xi, 1-158.
32. Rodgers M, McKenna C, Palmer S, et al. Curative catheter ablation in atrial fibrillation and typical atrial flutter: Systematic review and economic evaluation. Health Technol Assess. 2008;12:iii-iv, xi-xiii, 1-198.
33. Rogowski W, Burch J, Palmer S, et al. The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: A systematic review and value of information analysis. Health Technol Assess. 2009;13:iii-iv, ix-xi, 1-77.
34. Soares MO, Welton NJ, Harrison DA, et al. An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): Incorporating a systematic review, meta-analysis and value of information analysis. Health Technol Assess. 2012;16:1-186.
35. Harris J, Felix L, Miners A, et al. Adaptive e-learning to improve dietary behaviour: A systematic review and cost-effectiveness analysis. Health Technol Assess. 2011;15:1-160.
36. Pandor A, Eastham J, Beverley C, Chilcott J, Paisley S. Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: A systematic review. Health Technol Assess. 2004;8:iii, 1-121.
37. Stevenson M, Lloyd-Jones M, Papaioannou D. Vitamin K to prevent fractures in older women: Systematic review and economic evaluation. Health Technol Assess. 2009;13:iii-xi, 1-134.
38. Stevenson MD, Scope A, Sutcliffe PA, et al. Group cognitive behavioural therapy for postnatal depression: A systematic review of clinical effectiveness, cost-effectiveness and value of information analyses. Health Technol Assess. 2010;14:1-107, iii-iv.